Literature DB >> 19719333

Interactions between herbal medicines and prescribed drugs: an updated systematic review.

Angelo A Izzo1, Edzard Ernst.   

Abstract

The concomitant use of herbal medicines and pharmacotherapy is wide spread. We have reviewed the literature to determine the possible interactions between seven popular herbal medicines (ginkgo, St John's wort, ginseng, garlic, echinacea, saw palmetto and kava) and conventional drugs. Literature searches were performed using MEDLINE, Cochrane Library and EMBASE and we identified 128 case reports or case series, and 80 clinical trials. Clinical trials indicate that St John's wort (Hypericum perforatum), via cytochrome P450 (CYP) and/or P-glycoprotein induction, reduces the plasma concentrations (and/or increases the clearance) of alprazolam, amitriptyline, atorvastatin, chlorzoxazone, ciclosporin, debrisoquine, digoxin, erythromycin, fexofenadine, gliclazide, imatinib, indinavir, irinotecan, ivabradine, mephenytoin, methadone, midazolam, nifedipine, omeprazole, oral contraceptives, quazepam, simvastatin, tacrolimus, talinolol, verapamil, voriconazole and warfarin. Case reports or case series suggest interactions of St John's wort with adrenergic vasopressors, anaesthetics, bupropion, buspirone, ciclosporin, eletriptan, loperamide, nefazodone, nevirapine, oral contraceptives, paroxetine, phenprocoumon, prednisone, sertraline, tacrolimus, theophylline, tibolone, tryptophan, venlafaxine and warfarin. Ginkgo (Ginkgo biloba) decreases the plasma concentrations of omeprazole, ritonavir and tolbutamide. Clinical cases indicate interactions of ginkgo with antiepileptics, aspirin (acetylsalicylic acid), diuretics, ibuprofen, risperidone, rofecoxib, trazodone and warfarin. Ginseng (Panax ginseng) may interact with phenelzine and warfarin. Kava (Piper methysticum) increases the clearance of chlorzoxazone (a CYP2E1 substrate) and may interact with alprazolam, levodopa and paroxetine. Garlic (Allium sativum) interacts with chlorpropamide, fluindione, ritonavir and warfarin; it also reduces plasma concentrations of chlorzoxazone (a CYP2E1 probe). Echinacea might affect the clearance of caffeine (a CYP1A2 probe) and midazolam (a CYP3A4 probe). No interactions have been reported for saw palmetto (Serenoa repens). Numerous interactions between herbal medicines and conventional drugs have been documented. While the significance of many interactions is uncertain, several interactions, particularly those with St John's wort, may have serious clinical consequences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19719333     DOI: 10.2165/11317010-000000000-00000

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  178 in total

Review 1.  St John's wort: Prozac from the plant kingdom.

Authors:  G Di Carlo; F Borrelli; E Ernst; A A Izzo
Journal:  Trends Pharmacol Sci       Date:  2001-06       Impact factor: 14.819

2.  Unexplained decrease of cyclosporin trough levels in a compliant renal transplant patient.

Authors:  A Mandelbaum; F Pertzborn; M Martin-Facklam; M Wiesel
Journal:  Nephrol Dial Transplant       Date:  2000-09       Impact factor: 5.992

3.  Probable interaction between warfarin and ginseng.

Authors:  K Janetzky; A P Morreale
Journal:  Am J Health Syst Pharm       Date:  1997-03-15       Impact factor: 2.637

4.  Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding.

Authors:  Patricia A Murphy; Steven E Kern; Frank Z Stanczyk; Carolyn L Westhoff
Journal:  Contraception       Date:  2005-06       Impact factor: 3.375

5.  Methadone maintenance treatment and St. John's Wort - a case report.

Authors:  D Eich-Höchli; R Oppliger; K Powell Golay; P Baumann; C B Eap
Journal:  Pharmacopsychiatry       Date:  2003-01       Impact factor: 5.788

6.  Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.

Authors:  Silke C Mueller; Bernhard Uehleke; Heike Woehling; Michael Petzsch; Jolanta Majcher-Peszynska; Eva-Maria Hehl; Hartwig Sievers; Bruno Frank; Anne-Kathrin Riethling; Bernd Drewelow
Journal:  Clin Pharmacol Ther       Date:  2004-06       Impact factor: 6.875

Review 7.  A critical evaluation of drug interactions with Echinacea spp.

Authors:  Camille Freeman; Kevin Spelman
Journal:  Mol Nutr Food Res       Date:  2008-07       Impact factor: 5.914

8.  Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts following tibolone and Hypericum perforatum (St. John's wort). Case of drug interaction?

Authors:  F Etogo-Asse; F Boemer; C Sempoux; A Geubel
Journal:  Acta Gastroenterol Belg       Date:  2008 Jan-Mar       Impact factor: 1.316

Review 9.  Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring.

Authors:  Shu-Feng Zhou; Charlie Changli Xue; Xue-Qing Yu; Chunguang Li; Guangji Wang
Journal:  Ther Drug Monit       Date:  2007-12       Impact factor: 3.681

10.  St John's wort: a hidden risk for transplant patients.

Authors:  S M Turton-Weeks; G W Barone; B J Gurley; B L Ketel; M L Lightfoot; S R Abul-Ezz
Journal:  Prog Transplant       Date:  2001-06       Impact factor: 1.065

View more
  138 in total

1.  Aloe vera non-decolorized whole leaf extract-induced large intestinal tumors in F344 rats share similar molecular pathways with human sporadic colorectal tumors.

Authors:  Arun R Pandiri; Robert C Sills; Mark J Hoenerhoff; Shyamal D Peddada; Thai-Vu T Ton; Hue-Hua L Hong; Gordon P Flake; David E Malarkey; Greg R Olson; Igor P Pogribny; Nigel J Walker; Mary D Boudreau
Journal:  Toxicol Pathol       Date:  2011-09-21       Impact factor: 1.902

2.  Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities.

Authors:  Mohamed-Eslam F Mohamed; Reginald F Frye
Journal:  Drug Metab Dispos       Date:  2011-06-01       Impact factor: 3.922

Review 3.  Clinically significant drug interactions with newer antidepressants.

Authors:  Edoardo Spina; Gianluca Trifirò; Filippo Caraci
Journal:  CNS Drugs       Date:  2012-01-01       Impact factor: 5.749

Review 4.  Drug interactions with herbal medicines.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Clin Pharmacokinet       Date:  2012-02-01       Impact factor: 6.447

Review 5.  Herb-drug interactions: an overview of systematic reviews.

Authors:  Paul Posadzki; Leala Watson; Edzard Ernst
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

6.  Herbal medicines and forensic investigations.

Authors:  Roger W Byard; Ian Musgrave
Journal:  Forensic Sci Med Pathol       Date:  2010-06       Impact factor: 2.007

7.  Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients.

Authors:  José Moltó; Marta Valle; Cristina Miranda; Samandhy Cedeño; Eugenia Negredo; Manuel José Barbanoj; Bonaventura Clotet
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

Review 8.  Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood-Cerebrospinal Fluid Barrier and Blood-Brain Barrier.

Authors:  Lilian W Kibathi; SoHyun Bae; Scott R Penzak; Parag Kumar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

Review 9.  Understanding interactions between Chinese medicines and pharmaceutical drugs in integrative healthcare.

Authors:  Kelvin Chan
Journal:  Chin J Integr Med       Date:  2014-12-19       Impact factor: 1.978

10.  Principles of pharmacological research of nutraceuticals.

Authors:  Ruth Andrew; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2017-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.